Genmab — Oktober 2017
-
-
Sjovt at ingen at de store pharma selskaber kan regne som Florian. De må snart få ansat nogle nye regnedrenge

-
Her er en anden artikel om det samme.https://www.icr.ac.uk/news-archive/new-myeloma-clinical-trial-launches-with-aim-to-transform-treatment-from-one-size-fits-all-approach
-
maybe they follow Scotland if they get a similar discount
http://www.pmlive.com/pharma_news/smc_backtracks_on_janssens_multiple_myeloma_treatment_darzalex_1207950
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind